Test Safety and Efficacy of Zotarolimus- and Everolimus-Eluting Stents (ZES/EES) Assessed by Optical Coherence Tomography

NCT01230723 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Coronary Heart Disease

Interventions

DEVICE: Everolimus-Eluting-Stent
DEVICE: Zotarolimus-Eluting-Stent

Sponsor

Deutsches Herzzentrum Muenchen